Máté Fullajtár, Brigitta Kakuszi, István Bitter, Pál Czobor
{"title":"社会环境下精神分裂症患者NoGo P300 ERP的改变:一项超扫描研究。","authors":"Máté Fullajtár, Brigitta Kakuszi, István Bitter, Pál Czobor","doi":"10.1038/s41398-025-03481-6","DOIUrl":null,"url":null,"abstract":"<p><p>Although patients with schizophrenia exhibit profound deficits in social cognition, studies into the neurobiological background of these deficits examined individuals in isolation, in single-person settings. We investigated the neurobiological basis of social cognitive deficits in a social setting, applying a novel approach using EEG-hyperscanning. Eighty subjects were included in the analyses, 49 healthy controls (HC) and 31 patients with schizophrenia. We recorded high-density EEG from pairs of participants, where one (the observer) watched their own screen while the other (the actor) actively performed a Go/NoGo task. The task was administered twice, with the participants switching roles. We focused on investigating the P300 event-related potential from the observer condition. The PANSS scale was used to characterize psychopathology. The Reading the Mind in the Eyes Test and the d-prime index were applied to characterize mentalization and signal detection ability. We found that patients with schizophrenia showed significant P300 reduction compared to the HC group at the first task exposure. They, however, exhibited augmented P300 with the repeated exposure, while HCs manifested a decrease. More severe positive symptoms were associated with larger P300 at both task-exposures. Moreover, poorer mentalization and signal detection performance were associated with decreased P300. Our findings provide evidence that P300 alterations in schizophrenia can be detected in social setting. The opposite changes in the two groups may be due to disparate reasons: habituation in HCs, whereas the alterations in patients may result from various factors, including deficient habituation and an aberrant processing of stimulus salience in a social setting.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"270"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331909/pdf/","citationCount":"0","resultStr":"{\"title\":\"Alterations of NoGo P300 ERP in schizophrenia in social setting: a hyperscanning study.\",\"authors\":\"Máté Fullajtár, Brigitta Kakuszi, István Bitter, Pál Czobor\",\"doi\":\"10.1038/s41398-025-03481-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Although patients with schizophrenia exhibit profound deficits in social cognition, studies into the neurobiological background of these deficits examined individuals in isolation, in single-person settings. We investigated the neurobiological basis of social cognitive deficits in a social setting, applying a novel approach using EEG-hyperscanning. Eighty subjects were included in the analyses, 49 healthy controls (HC) and 31 patients with schizophrenia. We recorded high-density EEG from pairs of participants, where one (the observer) watched their own screen while the other (the actor) actively performed a Go/NoGo task. The task was administered twice, with the participants switching roles. We focused on investigating the P300 event-related potential from the observer condition. The PANSS scale was used to characterize psychopathology. The Reading the Mind in the Eyes Test and the d-prime index were applied to characterize mentalization and signal detection ability. We found that patients with schizophrenia showed significant P300 reduction compared to the HC group at the first task exposure. They, however, exhibited augmented P300 with the repeated exposure, while HCs manifested a decrease. More severe positive symptoms were associated with larger P300 at both task-exposures. Moreover, poorer mentalization and signal detection performance were associated with decreased P300. Our findings provide evidence that P300 alterations in schizophrenia can be detected in social setting. The opposite changes in the two groups may be due to disparate reasons: habituation in HCs, whereas the alterations in patients may result from various factors, including deficient habituation and an aberrant processing of stimulus salience in a social setting.</p>\",\"PeriodicalId\":23278,\"journal\":{\"name\":\"Translational Psychiatry\",\"volume\":\"15 1\",\"pages\":\"270\"},\"PeriodicalIF\":6.2000,\"publicationDate\":\"2025-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331909/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41398-025-03481-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03481-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Alterations of NoGo P300 ERP in schizophrenia in social setting: a hyperscanning study.
Although patients with schizophrenia exhibit profound deficits in social cognition, studies into the neurobiological background of these deficits examined individuals in isolation, in single-person settings. We investigated the neurobiological basis of social cognitive deficits in a social setting, applying a novel approach using EEG-hyperscanning. Eighty subjects were included in the analyses, 49 healthy controls (HC) and 31 patients with schizophrenia. We recorded high-density EEG from pairs of participants, where one (the observer) watched their own screen while the other (the actor) actively performed a Go/NoGo task. The task was administered twice, with the participants switching roles. We focused on investigating the P300 event-related potential from the observer condition. The PANSS scale was used to characterize psychopathology. The Reading the Mind in the Eyes Test and the d-prime index were applied to characterize mentalization and signal detection ability. We found that patients with schizophrenia showed significant P300 reduction compared to the HC group at the first task exposure. They, however, exhibited augmented P300 with the repeated exposure, while HCs manifested a decrease. More severe positive symptoms were associated with larger P300 at both task-exposures. Moreover, poorer mentalization and signal detection performance were associated with decreased P300. Our findings provide evidence that P300 alterations in schizophrenia can be detected in social setting. The opposite changes in the two groups may be due to disparate reasons: habituation in HCs, whereas the alterations in patients may result from various factors, including deficient habituation and an aberrant processing of stimulus salience in a social setting.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.